Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Conference Call February 22, 2024 8:30 AM ET Company Participants Bryan Dunn – Head-Investor Relations Will Lewis – Chairman and Chief Executive Officer Sara Bonstein – Chief Financial Officer Conference Call Participants Nick Lenard – J.P. Morgan Jennifer Kim – Cantor Fitzgerald Tiago Fauth – Wells Fargo Andrea Tan – Goldman Sachs Joseph Schwartz – Leerink Partners Ritu Baral – TD Cowen Vamil Divan – Guggenheim Securities Jeff Hung – Morgan Stanley Liisa B ...

Exhibit 99.1 Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update —Topline Data from the Phase 3 ASPEN Trial of Brensocatib in Adult Patients with Bronchiectasis Remain on Track to Read Out in the Latter Part of Second-Quarter 2024— —Enrollment in the Phase 2 Study of TPIP in Patients with PH-ILD Completed in November 2023; Topline Data Expected in Second- Quarter 2024 Ahead of the ASPEN Readout— —Company Ends 2023 With $780 Million of Cash, Cash Equivalents, and M ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia (State or other jurisdiction ...

Insmed, Inc. (NASDAQ:INSM) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Bryan Dunn - IR William Lewis - President, CEO & Chairman Sara Bonstein - CFO Conference Call Participants Andrea Tan - Goldman Sachs Group Jennifer Kim - Cantor Fitzgerald & Co. Vamil Divan - Guggenheim Securities Ritu Baral - TD Cowen Liisa Bayko - Evercore ISI Joseph Schwartz - Leerink Partners Jason Zemansky – Bank of America Merrill Lynch Graig Suvannavejh - Mizuho Securities Leiyang Wang - Barc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdi ...

Insmed Incorporated (NASDAQ:INSM) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Bryan Dunn - Head, IR William Lewis - Chair & CEO Sara Bonstein - CFO Martina Flammer - Chief Medical Officer Conference Call Participants Judah Frommer - Credit Suisse Vamil Divan - Guggenheim Jennifer Kim - Cantor Fitzgerald Leon Wang - Barclays Jason Zemansky - Bank of America Stephen Willey - Stifel Liisa Bayko - Evercore Andrea Tan - Goldman Sachs Joseph Schwartz - Leerink Partners Operator ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdiction ...

Insmed Incorporated (NASDAQ:INSM) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Bryan Dunn - Head of Investor Relations Will Lewis - Chair and Chief Executive Officer Sara Bonstein - Chief Financial Officer Martina Flammer - Chief Medical Officer Conference Call Participants Nick Lenard - JPMorgan Andrea Tan - Goldman Sachs Judah Frommer - Credit Suisse Jennifer Kim - Cantor Fitzgerald Leon Wang - Barclays Stephen Willey - Stifel Jason Zemansky - Bank of America Liisa Bayko - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdictio ...

Insmed Incorporated (NASDAQ:INSM) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Eleanor Barisser - IR Will Lewis - Chair and CEO Sara Bonstein - CFO Conference Call Participants Jason Zemansky - Bank of America Jeff Hung - Morgan Stanley Andrea Tan - Goldman Sachs Judah Frommer - Credit Suisse Joseph Schwartz - SVB Securities Stephen Willey - Stifel Leon Wang - Barclays Graig Suvannavejh - Mizuho Securities Jennifer Kim - Cantor Fitzgerald Operator Hello everyone and wel ...